Geoffrey L Uy (G L Uy, Geoff Uy)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Venues

Blood advances

Blood

Leukemia

JCO oncology practice

Washington University School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Washington University School of Medicine Jul 1o 2020

United States

Professor of Medicine :: Division of Oncology

Publications

Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, Daelynn R Buelow, Sydney Fobare, Christopher C Oakes, Jonathan E Kolitz, Geoffrey L Uy, Wendy Stock, Bayard L Powell, Deedra Nicolet, Erin K Hertlein, Krzysztof Mrózek, James S Blachly, Ann-Kathrin Eisfeld, Sharyn D Baker, John C Byrd
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia (Alliance). Blood advances (2023)
Melanie Rebechi, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S Mims, James S Blachly, Shelley J Orwick, Karilyn T M Larkin, Christopher C Oakes, Andrew Hantel, Andrew J Carroll, William Blum, Bayard L Powell, Geoffrey L Uy, Richard M Stone, Richard A Larson, John C Byrd, Electra D Paskett, Jesse J Plascak, Ann-Kathrin Eisfeld
Association of social deprivation with survival in younger adult patients with AML: an Alliance study. Blood advances (2023)
Danielle Novetsky Friedman, Irenaeus Chi-Chung Chan, Chaya S Moskowitz, Shanita Li, Kimberly R Turner, Jie Liu, Nancy Bouvier, Michael F Walsh, Barbara Spitzer, Andrew L Kung, Michael Berger, Megan Anne Cooper, Iskra Pusic, Geoffrey L Uy, Daniel C Link, Todd E Druley, Luis A Diaz, Ross L Levine, Neerav Narendra Shukla, Kelly L Bolton
Clonal Hematopoiesis in Survivors of Childhood Cancer. Blood advances (2023)
Krzysztof Mrózek, Jessica Kohlschmidt, James S Blachly, Deedra Nicolet, Andrew J Carroll, Kellie J Archer, Alice S Mims, Karilyn T Larkin, Shelley J Orwick, Christopher C Oakes, Jonathan E Kolitz, Bayard L Powell, William G Blum, Guido Marcucci, Maria R Baer, Geoffrey L Uy, Wendy Stock, John C Byrd, Ann-Kathrin Eisfeld
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. Leukemia (2023)
Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, Daelynn R Buelow, Sydney Fobare, Christopher C Oakes, Jonathan E Kolitz, Geoffrey L Uy, Wendy Stock, Bayard L Powell, Deedra Nicolet, Erin K Hertlein, Krzysztof Mrózek, James S Blachly, Ann-Kathrin Eisfeld, Sharyn D Baker, John C Byrd
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study. Blood advances 7 (16) (2023)
Vijaya Raj Bhatt, Geoffrey L Uy, Heidi D Klepin
Determining Treatment Tolerance and Fitness for Intensive Chemotherapy in Older Adults with AML: A Call to Action. Blood (2023)
Vijaya Raj Bhatt, Angela M Ulrich, Geoffrey L Uy, Richard M Stone, Wendy Stock, Michael O Ojelabi, Jun Yin, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, Maria R Baer, Selina Chow, Heidi D Klepin, Jennifer G Le-Rademacher, Aminah Jatoi
Outcomes of Older Adults With AML Treated in Community Versus Academic Centers: An Analysis of Alliance Trials. JCO oncology practice (2023)
Zachary D Crees, Michael P Rettig, Asad Bashey, Steven M Devine, Samantha M Jaglowski, Fei Wan, Amy Zhou, Melinda Harding, Abi Vainstein-Haras, Ella Sorani, Irit Gliko-Kabir, Brenda J Grossman, Peter Westervelt, John F DiPersio, Geoffrey L Uy
Hematopoietic Stem Cell Mobilization for Allogeneic Stem Cell Transplantation by Motixafortide, a Novel CXCR4 Inhibitor. Blood advances (2023)
Guillermo Garcia Manero, Nikolai A Podoltsev, Megan K D Othus, John M Pagel, Jerald P Radich, Min Fang, David A Rizzieri, Guido Marcucci, Stephen A Strickland, Mark R Litzow, M Lynn Savoie, Bruno C Medeiros, Mikkael A Sekeres, Tara L Lin, Geoffrey L Uy, Bayard L Powell, Jonathan E Kolitz, Richard A Larson, Richard M Stone, David F Claxton, James Essell, Selina M Luger, Sanjay R Mohan, Anna B Moseley, Frederick R Appelbaum, Harry P Erba
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML. Leukemia (2023)
Geoffrey L Uy, Laura F Newell, Tara L Lin, Stuart L Goldberg, Matthew J Wieduwilt, Robert J Ryan, Stefan Faderl, Jeffrey E Lancet
Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML. Blood advances 6 (17) (2022)
Erica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, Monique Chavez, Katie M Campbell, Kelsy C Cotto, Nicholas C Spies, Marianna B Ruzinova, Tianjiao Wang, Brooj Abro, Friederike Kreisel, Bijal A Parikh, Eric J Duncavage, John L Frater, Yi-Shan Lee, Anjum Hassan, Justin King, Daniel R Kohnen, Mark A Fiala, John S S Welch, Geoffrey L Uy, Kiran Vij, Ravi Vij, Malachi Griffith, Malachi Griffith, Lukas D Wartman
Distinct clonal identities of B-ALLs arising after Lenolidomide therapy for multiple myeloma. Blood advances (2022)
Geoffrey L Uy
Turning AML targets inside out. Blood 138 (25) (2022)
Armin Ghobadi, Michael Slade, Hagop Kantarjian, Julio Alvarenga, Ibrahim Aldoss, Kahee A Mohammed, Elias Jabbour, Rawan Faramand, Bijal Shah, Frederick Locke, Warren Fingrut, Jae H Park, Nicholas James Short, Feng Gao, Geoffrey L Uy, Peter Westervelt, John F DiPersio, Richard E Champlin, Monzr M Al Malki, Farhad Ravandi, Partow Kebriaei
The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis. Blood 140 (20) (2022)
Melissa M Berrien-Elliott, Michelle Becker-Hapak, Amanda F Cashen, Miriam T Jacobs, Pamela Wong, Mark Foster, Ethan McClain, Sweta Desai, Patrick Pence, Sarah Cooley, Claudio G Brunstein, Feng Gao, Camille N Abboud, Geoffrey L Uy, Peter Westervelt, Meagan A Jacoby, Iskra Pusic, Keith Stockerl-Goldstein, Mark A Schroeder, John F DiPersio, Patrick Soon-Shiong, Jeffrey S Miller, Todd A Fehniger
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy. Blood (2021)
Jingyu Xiang, Min Shi, Mark A Fiala, Feng Gao, Michael P Rettig, Geoffrey L Uy, Mark G Frattini, Katherine N Weilbaecher, Keith Stockerl-Goldstein, Shamim Mollah, John F DiPersio
Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors. Blood advances (2021)
Courtney D Di Nardo, Eytan M Stein, Arnaud Pigneux, Jessica K Altman, Robert H Collins, Harry P Erba, Justin M Watts, Geoffrey L Uy, Thomas Winkler, Hongfang Wang, Sung Choe, Hua Liu, Bin Wu, Stephanie M Kapsalis, Gail J Roboz, Stéphane de Botton
Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant. Leukemia 35 (11) (2021)
Melissa M Berrien-Elliott, Amanda F Cashen, Celia C Cubitt, Carly C Neal, Pamela Wong, Julia A Wagner, Mark Foster, Timothy Schappe, Sweta Desai, Ethan McClain, Michelle Becker-Hapak, Jennifer A Foltz, Matthew L Cooper, Natalia Jaeger, Sridhar Nonavinkere Srivatsan, Feng Gao, Rizwan Romee, Camille N Abboud, Geoffrey L Uy, Peter Westervelt, Meagan A Jacoby, Iskra Pusic, Keith E Stockerl-Goldstein, Mark G Frattini, John DiPersio, Todd A Fehniger
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia. Cancer discovery 10 (12) (2020)
Geoffrey L Uy, M P Rettig, R M Stone, M Y Konopleva, M Andreeff, K McFarland, W Shannon, T R Fletcher, T Reineck, W Eades, Keith E Stockerl-Goldstein, C N Abboud, M A Jacoby, P Westervelt, J F DiPersio
A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia. Blood cancer journal 7 (3) (2017)

Geoffrey L Uy.css-eqlu8i{font-size:small;padding-left:4px;} (G L Uy, Geoff Uy)

Publication Activity (10 Years)

Top Topics

Top Venues

Geoffrey L Uy (G L Uy, Geoff Uy)